Skip to content

Activity, Diet and Blood Pressure Trial

A randomised phase III study to evaluate the effects of a lifestyle program in the treatment of hypertension to lower blood pressure and decrease antihypertensive drug needs.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12605000090617
Acronym
ADAPT
Enrollment
200
Registered
2005-08-05
Start date
2001-01-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Intervention and 1-year follow-up have been completed. Further 2-year follow-up is in progress.

Interventions

Behavioural program promoting weight loss, a low-sodium DASH-type diet, high in fish, increased physical activity & reduced alcohol intake with 4 months intervention and follow-up at 1 and 3 years after completion of the intervention.

Sponsors

None
Lead Sponsor

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

BMI>25 kg/m2, treated with one or two antihypertensive drugs for at least 3 months.

Exclusion criteria

Clinic BP > 160/90 mm Hg; consumption > 2 fish meals or 4 fish oil capsules per week; alcohol intake > 4 standard drinks/day for women and 6 standard drinks/day for men; drug- or insulin-treated diabetes; chronic renal failure (serum creatinine>120 umol/L); chronic liver disease; symptomatic cardiovascular disease < 3 months; other chronic debilitating disease; the use of antihypertensive drugs for indications other than hypertension, such as the use of beta blockers for arrhythmias

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026